We serve Chemical Name:tetradecyl 3,4,5-trihydroxybenzoate CAS:18244-73-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:tetradecyl 3,4,5-trihydroxybenzoate
CAS.NO:18244-73-0
Synonyms:tetradecyl gallate;EINECS 242-118-7;3,4,5-trihydroxy-benzoic acid tetradecyl ester;n-tetradecyl gallate;Gallussaeure-tetradecylester;3,4,5-Trihydroxy-benzoesaeure-tetradecylester
Molecular Formula:C21H34O5
Molecular Weight:366.49200
HS Code:2918290000
Physical and Chemical Properties:
Melting point:N/A
Boiling point:542.1ºC at 760mmHg
Density:1.086g/cm3
Index of Refraction:1.528
PSA:86.99000
Exact Mass:366.24100
LogP:5.66130
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like tetradecyl gallate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3,4,5-Trihydroxy-benzoesaeure-tetradecylester physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,EINECS 242-118-7 Use and application,EINECS 242-118-7 technical grade,usp/ep/jp grade.
Related News: Resonant exploits its proprietary IMPaCT tumor microenvironment models and data platform to discover novel, unappreciated targets and functionally active anti-tumor antibodies for difficult to treat tumors. tetradecyl 3,4,5-trihydroxybenzoate manufacturer Rigosertib is a small molecule that inhibits cellular signaling in cancer cells by acting as a RAS mimetic. Current clinical development of rigosertib is centered upon the therapeutic management of MDS, a heterogeneous group of bone marrow disorders characterized by ineffective hematopoiesis that often develop into acute myeloid leukaemia (AML). tetradecyl 3,4,5-trihydroxybenzoate supplier Resonant exploits its proprietary IMPaCT tumor microenvironment models and data platform to discover novel, unappreciated targets and functionally active anti-tumor antibodies for difficult to treat tumors. tetradecyl 3,4,5-trihydroxybenzoate vendor Resonant exploits its proprietary IMPaCT tumor microenvironment models and data platform to discover novel, unappreciated targets and functionally active anti-tumor antibodies for difficult to treat tumors. tetradecyl 3,4,5-trihydroxybenzoate factory A new case of coronavirus has been reported in the United Arab Emirates, the country’s fifth, the Ministry of Health and Prevention announced on Saturday.
